• Challenges Facing Cell & Gene Therapy Clinical Trials

    May 17 | Clinical Research News | Clinical trials are the bedrock for developing advanced treatments within the life-saving field of cell and gene therapy. Despite significant strides, these trials encounter multi-faceted challenges that threaten to impede the progress of important new therapies. More
  • Clinical Trial Underway for New-and-Improved Prostate Cancer Test

    May 14 | Clinical Research News | Researchers at the University of Michigan (U-M) have developed a urine test for prostate cancer known as MyProstateScore 2.0 (MPS2), now a property of spinoff LynxDx, which they expect to significantly improve upon the performance of existing assays by focusing on clinically significant cancers and capturing more biomarkers in a single test. More
  • How Patient-Mediated Research Can Disrupt Life Sciences

    May 10 | Clinical Research News | The life science industry is changing. There are growing calls for real-world evidence (RWE) and feedback from patients (PROs). Rare diseases are growing in importance, and there is increasing recognition of equity as an ethical and drug-efficacy necessity. More
  • Functional Precision Medicine Shows Promise for Kids With Tough Cancers

    May 09 | Clinical Research News | A cancer researcher at Florida International University (FIU) has developed a functional precision medicine (FPM) approach to oncology treatment decision-making that combines genomic profiling with drug sensitivity testing on patient-derived tumor cells. Children with relapsed or refractory cancers are among the initial beneficiaries. More
  • Thermo Fisher on the Rise of Next-Generation Sequencing CDx

    May 07 | Clinical Research News | In oncology, it is well appreciated that time is life. Diagnostics are therefore valuable not just to determine the disease state of patients but how best to treat them, says Jane Li, senior director of oncology, pharma, and CRO partnerships related to clinical sequencing at Thermo Fisher Scientific. More
  • eConsent In Decentralized Clinical Trials - A Path To Participant Empowerment And Transparency

    May 03 | Clinical Research News | Electronic consent, or eConsent, has emerged as a cornerstone in the decentralized clinical trials (DCTs) landscape. Central to this is the Food and Drug Administration’s (FDA) resounding endorsement of electronic methodologies for obtaining informed consent from clinical trial participants. More
  • New Test Looks at Unique Response of MS Patients to Epstein-Barr Virus

    May 01 | Clinical Research News | Significant evidence now exists implicating the Epstein-Barr virus (EBV) as a causal factor in the development of multiple sclerosis (MS), making treatment of the virus a priority. To that end, research scientists at Trinity College Dublin have developed a blood test to measure the immune response to EBV that could be used as an outcome measure in future clinical trials in people with established MS. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.